TOBRADEX

3MG/ML+1MG/ML OPH GTT SUS 1X5ML

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Cessation of marketing 10.10.2017 0225172
Placing on the market 01.07.2000

All reports are available in the Overview.

Back to list